ELISA Diagnostics Tests Market Overview
The rising prevalence of infectious disease among animals and increasing incidences of human infections are the major factors driving the market growth. North America accounts for the major market share closely followed by Europe. The US holds the major market share owing the increasing prevalence of infectious diseases among humans and animals leads to the increased use of ELISA diagnostics test followed by the new product launches by major market players headquartered in the country. Asia Pacific is anticipated to register a significant growth rate owing to the rising animal-associated infection to humans is a standalone factor responsible for the influential market growth in Asia Pacific region. China is one of the major countries where ecology poses a risk for emerging, re-emerging, and novel diseases that could threaten China and the Rest of world owing to the vast population of ~ 1.4 billion and 50% of the world’s livestock. However, The ELISA diagnostic test market in India is expected to flourish during the forecast period owing to increasing government funding, rising healthcare costs, and growing adoption of technologically advanced diagnostic equipment in healthcare organizations.